Investors & Media

SEC Filing Details

Investor Relations Menu
Financials & Filings
Investor Contact

Adam Levy
Senior Vice President,
Investor Relations
alevy@zentalis.com

Emily White
Solebury Strategic Communications
ewhite@soleburystrat.com

Media Contact

Julia Deutsch
Solebury Strategic Communications
jdeutsch@soleburystrat.com

Document Details

Filing Date
Apr 28, 2023
Document Date
Apr 28, 2023
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Zentalis Pharmaceuticals
Issuer
ZENTALIS PHARMACEUTICALS, INC.